PL2424870T3 - Środki terapeutyczne 713 - Google Patents
Środki terapeutyczne 713Info
- Publication number
- PL2424870T3 PL2424870T3 PL10718670T PL10718670T PL2424870T3 PL 2424870 T3 PL2424870 T3 PL 2424870T3 PL 10718670 T PL10718670 T PL 10718670T PL 10718670 T PL10718670 T PL 10718670T PL 2424870 T3 PL2424870 T3 PL 2424870T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17463009P | 2009-05-01 | 2009-05-01 | |
| PCT/GB2010/050698 WO2010125390A1 (en) | 2009-05-01 | 2010-04-29 | Therapeutic agents 713 |
| EP10718670.2A EP2424870B1 (en) | 2009-05-01 | 2010-04-29 | Therapeutic agents 713 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2424870T3 true PL2424870T3 (pl) | 2016-05-31 |
Family
ID=42290768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10718670T PL2424870T3 (pl) | 2009-05-01 | 2010-04-29 | Środki terapeutyczne 713 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8110566B2 (pl) |
| EP (1) | EP2424870B1 (pl) |
| JP (1) | JP5763052B2 (pl) |
| KR (1) | KR20120023044A (pl) |
| CN (2) | CN102459279B (pl) |
| AR (1) | AR076516A1 (pl) |
| AU (1) | AU2010243341B2 (pl) |
| BR (1) | BRPI1014387A2 (pl) |
| CA (1) | CA2759230A1 (pl) |
| DK (1) | DK2424870T3 (pl) |
| ES (1) | ES2562831T3 (pl) |
| HR (1) | HRP20160128T1 (pl) |
| HU (1) | HUE026856T2 (pl) |
| MX (1) | MX2011011618A (pl) |
| PL (1) | PL2424870T3 (pl) |
| PT (1) | PT2424870E (pl) |
| RU (1) | RU2526055C2 (pl) |
| SA (1) | SA110310332B1 (pl) |
| SI (1) | SI2424870T1 (pl) |
| SM (1) | SMT201600041B (pl) |
| TW (1) | TW201100433A (pl) |
| UY (1) | UY32593A (pl) |
| WO (1) | WO2010125390A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010507619A (ja) * | 2006-10-25 | 2010-03-11 | ノイロサーチ アクティーゼルスカブ | オキサジアゾール及びチアジアゾール化合物並びにニコチン性アセチルコリン受容体調節物質としてのその使用 |
| EA201291384A1 (ru) * | 2010-07-06 | 2013-07-30 | Астразенека Аб | Терапевтические агенты 976 |
| UY34194A (es) | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? |
| HU230880B1 (hu) | 2015-04-15 | 2018-11-29 | Richter Gedeon Nyrt | Indol származékok |
| CN119490431A (zh) | 2019-03-15 | 2025-02-21 | 总医院公司 | Tead转录因子的新型小分子抑制剂 |
| EP4076527A4 (en) * | 2020-01-10 | 2024-05-15 | Consynance Therapeutics, Inc. | Therapeutic combinations of drugs and methods of using them |
| HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2366652C2 (ru) * | 2002-02-01 | 2009-09-10 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Амиды аминоалкилзамещенных азетидинов, пирролидинов, пиперидинов и азепанов |
| SE0202134D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| CA2494102A1 (en) * | 2002-07-30 | 2004-02-05 | Banyu Pharmaceutical Co., Ltd. | Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| WO2004072018A1 (ja) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | アミン誘導体 |
| US20060293298A1 (en) * | 2003-04-10 | 2006-12-28 | Bamford Mark J | Compounds |
| GB0400193D0 (en) | 2004-01-07 | 2004-02-11 | Astrazeneca Ab | Therapeutic agents |
| JP2007517868A (ja) | 2004-01-07 | 2007-07-05 | アストラゼネカ アクチボラグ | 治療薬i |
| US7241787B2 (en) * | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| TW200538098A (en) * | 2004-03-22 | 2005-12-01 | Astrazeneca Ab | Therapeutic agents |
| DE602005014786D1 (de) * | 2004-07-26 | 2009-07-16 | Lilly Co Eli | Oxazolderivate als histamin-h3-rezeptor-wirkstoffe, deren herstellung und therapeutische verwendung |
| WO2006044228A1 (en) | 2004-10-18 | 2006-04-27 | Eli Lilly And Company | Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| ATE404555T1 (de) | 2004-12-17 | 2008-08-15 | Lilly Co Eli | Neue mch-rezeptorantagonisten |
| US20080306055A1 (en) * | 2004-12-21 | 2008-12-11 | Astrazeneca Ab | Heterocyclic Mchr1 Antagonists And Their Use In Therapy |
| JP2006176443A (ja) | 2004-12-22 | 2006-07-06 | Shionogi & Co Ltd | メラニン凝集ホルモン受容体アンタゴニスト |
| US20080269275A1 (en) * | 2005-05-31 | 2008-10-30 | Astrazeneca Ab | Novel Mchr1 Antagonists and Their Use for the Treatment of Mchr1 Mediated Conditions and Disorders |
| WO2007011284A1 (en) | 2005-07-15 | 2007-01-25 | Astrazeneca Ab | Therapeutic agents |
| JP2009522354A (ja) | 2006-01-06 | 2009-06-11 | アストラゼネカ・アクチエボラーグ | 化合物 |
| EP2051977A2 (en) | 2006-07-20 | 2009-04-29 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
| WO2008020799A1 (en) | 2006-08-18 | 2008-02-21 | Astrazeneca Ab | Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists |
| MX2009005908A (es) | 2006-12-05 | 2009-06-16 | Janssen Pharmaceutica Nv | Derivados novedosos de diaza-espiro-piridinona sustituidos para usarse en las enfermedades mediadas por la hormona concentradora de melanina 1. |
| BRPI0721086A2 (pt) | 2006-12-14 | 2014-02-25 | Lilly Co Eli | Derivados de 5-[4-(azetidin-3-ilóxi)-fenil]-2-fenil-5h-tiazolo[5,4-c]piri din-4-ona e seu emprego como antago-nistas de receptor de mch |
| JP2010524962A (ja) | 2007-04-17 | 2010-07-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | オーロラキナーゼ阻害剤のための創薬法 |
| CN101861302A (zh) | 2007-08-22 | 2010-10-13 | 弗·哈夫曼-拉罗切有限公司 | 作为nk3受体拮抗剂的吡咯烷芳基-醚 |
| RU2477720C2 (ru) | 2007-10-17 | 2013-03-20 | Санофи-Авентис | Замещенные n-фенилбипирролидинкарбоксамиды и их применение в лечебных целях |
| AU2009261248A1 (en) * | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
-
2010
- 2010-04-28 SA SA110310332A patent/SA110310332B1/ar unknown
- 2010-04-29 TW TW099113722A patent/TW201100433A/zh unknown
- 2010-04-29 DK DK10718670.2T patent/DK2424870T3/en active
- 2010-04-29 WO PCT/GB2010/050698 patent/WO2010125390A1/en not_active Ceased
- 2010-04-29 HU HUE10718670A patent/HUE026856T2/en unknown
- 2010-04-29 SI SI201031124T patent/SI2424870T1/sl unknown
- 2010-04-29 KR KR1020117028655A patent/KR20120023044A/ko not_active Ceased
- 2010-04-29 RU RU2011147751/04A patent/RU2526055C2/ru not_active IP Right Cessation
- 2010-04-29 CA CA2759230A patent/CA2759230A1/en not_active Abandoned
- 2010-04-29 ES ES10718670.2T patent/ES2562831T3/es active Active
- 2010-04-29 MX MX2011011618A patent/MX2011011618A/es active IP Right Grant
- 2010-04-29 BR BRPI1014387A patent/BRPI1014387A2/pt not_active IP Right Cessation
- 2010-04-29 CN CN201080031068.6A patent/CN102459279B/zh not_active Expired - Fee Related
- 2010-04-29 PT PT107186702T patent/PT2424870E/pt unknown
- 2010-04-29 JP JP2012507821A patent/JP5763052B2/ja not_active Expired - Fee Related
- 2010-04-29 AU AU2010243341A patent/AU2010243341B2/en not_active Ceased
- 2010-04-29 HR HRP20160128TT patent/HRP20160128T1/hr unknown
- 2010-04-29 EP EP10718670.2A patent/EP2424870B1/en not_active Not-in-force
- 2010-04-29 CN CN201410183568.1A patent/CN103936751A/zh active Pending
- 2010-04-29 PL PL10718670T patent/PL2424870T3/pl unknown
- 2010-04-30 UY UY0001032593A patent/UY32593A/es not_active Application Discontinuation
- 2010-04-30 AR ARP100101476A patent/AR076516A1/es not_active Application Discontinuation
- 2010-04-30 US US12/771,594 patent/US8110566B2/en not_active Expired - Fee Related
-
2016
- 2016-02-11 SM SM201600041T patent/SMT201600041B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010243341A1 (en) | 2011-11-03 |
| JP2012525365A (ja) | 2012-10-22 |
| CA2759230A1 (en) | 2010-11-04 |
| WO2010125390A1 (en) | 2010-11-04 |
| CN102459279A (zh) | 2012-05-16 |
| US20100280000A1 (en) | 2010-11-04 |
| ES2562831T3 (es) | 2016-03-08 |
| AU2010243341B2 (en) | 2014-02-13 |
| SMT201600041B (it) | 2016-02-25 |
| BRPI1014387A2 (pt) | 2017-06-06 |
| HUE026856T2 (en) | 2016-07-28 |
| SI2424870T1 (sl) | 2016-03-31 |
| UY32593A (es) | 2010-11-30 |
| JP5763052B2 (ja) | 2015-08-12 |
| CN103936751A (zh) | 2014-07-23 |
| DK2424870T3 (en) | 2016-02-15 |
| TW201100433A (en) | 2011-01-01 |
| EP2424870B1 (en) | 2015-12-16 |
| CN102459279B (zh) | 2014-06-25 |
| HRP20160128T1 (hr) | 2016-02-26 |
| AR076516A1 (es) | 2011-06-15 |
| MX2011011618A (es) | 2011-11-18 |
| PT2424870E (pt) | 2016-03-17 |
| US8110566B2 (en) | 2012-02-07 |
| KR20120023044A (ko) | 2012-03-12 |
| EP2424870A1 (en) | 2012-03-07 |
| SA110310332B1 (ar) | 2013-12-10 |
| RU2526055C2 (ru) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0811304D0 (en) | Therapeutic agents | |
| GB0908957D0 (en) | Therapeutic agents | |
| GB0811643D0 (en) | New therapeutic agents | |
| GB0819593D0 (en) | Therapeutic agents | |
| ZA200906525B (en) | Therapeutic agents | |
| GB0921075D0 (en) | Novel combination of the therapeutic agents | |
| GB0821693D0 (en) | Therapeutic agents | |
| GB0801081D0 (en) | Therapeutic agents | |
| GB0723747D0 (en) | Therapeutic agents | |
| GB0801080D0 (en) | Therapeutic agents | |
| GB0812309D0 (en) | Therapeutic agents | |
| GB0805818D0 (en) | Therapeutic agents | |
| GB0724340D0 (en) | Novel Therapeutic Agents | |
| PL2424870T3 (pl) | Środki terapeutyczne 713 | |
| EP2454276A4 (en) | THERAPEUTIC AGENTS | |
| GB0723748D0 (en) | Therapeutic agents | |
| GB0910493D0 (en) | Therapeutic agents | |
| GB0811715D0 (en) | Therapeutic agents | |
| GB0903949D0 (en) | Therapeutic agents | |
| GB0919824D0 (en) | Therapeutic agents | |
| GB0919819D0 (en) | Therapeutic agents | |
| GB0919821D0 (en) | Therapeutic agents | |
| GB0911965D0 (en) | Therapeutic agents | |
| GB0914533D0 (en) | Therapeutic agents | |
| GB0915586D0 (en) | Therapeutic agents |